Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Result of AGM

18 Jun 2024 16:53

RNS Number : 9301S
Ceiba Investments Limited
18 June 2024
 

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

RESULT OF ANNUAL GENERAL MEETING

 

The Company advises that for the annual general meeting held on 18 June 2024 valid proxy appointments were made in respect of 52,251,153 ordinary shares of the Company in issue, being 37.95% of the total ordinary shares of the Company in issue, and all resolutions were passed. 

 

The full voting results were as follows: - 

 

Ordinary Resolutions

For

 

Against

 

TOTAL VOTES CAST

Votes withheld

No. of Votes

%

No. of Votes

%

No. of Votes

No. of Votes

1

Receive the 2023 Annual Report and Consolidated Financial Statements

52,251,153

100

-

-

52,251,153

-

2

Re-appointment of Grant Thornton Limited, Guernsey as Auditor of the Company

52,251,153

100

-

-

52,251,153

-

3

Authorise the Directors to fix the remuneration of the Company's Auditor

52,251,153

100

-

-

52,251,153

-

4

Re-appointment of John Herring as a Director of the Company

52,251,153

100

-

-

52,251,153

-

5

Re-appointment of Trevor Bowen as a Director of the Company

52,251,153

100

-

-

52,251,153

-

6

Re-appointment of Keith Corbin as a Director of the Company

52,251,153

100

-

-

52,251,153

-

7

Re-appointment of Jemma Freeman as a Director of the Company

52,251,153

100

-

-

52,251,153

-

8

Re-appointment of Andrew Pegge as a Director of the Company

52,251,153

100

-

-

52,251,153

-

9

Market Purchases

 

52,251,153

100

-

-

52,251,153

-

 

Extraordinary Resolution

For

Against

TOTAL VOTES CAST

Votes withheld

No. of Votes

%

No of Votes

%

No. of votes

No. of votes

10

Limited disapplication of pre-emption rights

52,154,653

99.82

96,500

0.18

52,251,153

-

 

For further information, please contact:

 

Sebastiaan Berger

 

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Finn Gordon (Corporate Finance)

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

 

 

www.ceibainvestments.co.uk

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFFFIAELSEIM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.